Is The Bad News Priced Into Nike Stock Now?
Despite its dominance in the athletic shoe and apparel industry,…
Buy
51
BFH Quote, Financials, Valuation and Earnings
Last price:
$44.81
Seasonality move
:
6.86%
Day range:
$48.80 - $52.11
52-week range:
$32.10 - $66.71
Dividend yield:
1.63%
P/E ratio:
9.29x
P/S ratio:
0.68x
P/B ratio:
0.83x
Volume:
482.3K
Avg. volume:
987.8K
1-year change:
47.41%
Market cap:
$2.5B
Revenue:
$3.8B
EPS (TTM):
$5.55
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.3B | $3.3B | $3.9B | $4.3B | $3.8B | |
| Revenue Growth (YoY) | -1.49% | -0.85% | 18.35% | 10.98% | -10.64% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $752M | $831M | $959M | $1B | $1B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $794M | $923M | $1.1B | $1.1B | $1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $301M | $1B | $300M | $968M | $381M | |
| Earnings of Discontinued Ops. | $6M | $4M | -$1M | -$19M | -$2M | |
| Income Tax Expense | $93M | $247M | $76M | $231M | $102M | |
| Net Income to Company | $214M | $801M | $223M | $718M | $277M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $214M | $801M | $223M | $718M | $277M | |
| Basic EPS (Cont. Ops) | $4.47 | $16.09 | $4.47 | $14.39 | $5.58 | |
| Diluted EPS (Cont. Ops) | $4.46 | $16.02 | $4.46 | $14.34 | $5.49 | |
| Weighted Average Basic Share | $47.8M | $49.7M | $49.9M | $49.8M | $49.6M | |
| Weighted Average Diluted Share | $47.9M | $50M | $50M | $50M | $50.4M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $800M | $1.4B | $803M | $1.8B | $1.3B | |
| Revenue (Reported) | $3.3B | $3.3B | $3.9B | $4.3B | $3.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $800M | $1.4B | $803M | $1.8B | $1.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -$113.5M | $854M | $1B | $1B | $925M | |
| Revenue Growth (YoY) | -- | -- | 20.96% | -1.55% | -9.05% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $678.8M | $229M | $263M | $266M | $290M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $664.5M | $251M | $296M | $290M | $312M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $52.7M | $64M | -$208M | $18M | -$27M | |
| Earnings of Discontinued Ops. | -- | -$42M | -- | -$1M | -- | |
| Income Tax Expense | $46.4M | $4M | -$74M | -$26M | -$34M | |
| Net Income to Company | $12.3M | $18M | -$134M | $43M | $7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $12.3M | $18M | -$134M | $43M | $7M | |
| Basic EPS (Cont. Ops) | $0.25 | $0.34 | -$2.69 | $0.91 | $0.14 | |
| Diluted EPS (Cont. Ops) | $0.25 | $0.34 | -$2.69 | $0.90 | $0.14 | |
| Weighted Average Basic Share | $48.1M | $49.7M | $49.9M | $49.2M | $49.6M | |
| Weighted Average Diluted Share | $48.5M | $50M | $50M | $49.4M | $50.7M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $52.7M | $149M | -$13M | $256M | $204M | |
| Revenue (Reported) | -$113.5M | $854M | $1B | $1B | $925M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $52.7M | $149M | -$13M | $256M | $204M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.3B | $3.3B | $3.9B | $4.3B | $3.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $752.1M | $830M | $960M | $1B | $1B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $2B | $922M | $1.1B | $1.1B | $1.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $301M | $1B | $299M | $967M | $381M | |
| Earnings of Discontinued Ops. | -- | $5M | -$1M | -$19M | -$2M | |
| Income Tax Expense | $93M | $247M | $76M | $231M | $103M | |
| Net Income to Company | $214M | $801M | $223M | $718M | $277M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $214M | $802M | $222M | $717M | $276M | |
| Basic EPS (Cont. Ops) | $4.48 | $16.10 | $4.47 | $14.40 | $5.59 | |
| Diluted EPS (Cont. Ops) | $4.48 | $16.02 | $4.45 | $14.35 | $5.55 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $301M | $1.4B | $801M | $1.8B | $1.3B | |
| Revenue (Reported) | $3.3B | $3.3B | $3.9B | $4.3B | $3.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $301M | $1.4B | $801M | $1.8B | $1.3B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.3B | $3.9B | $4.3B | $3.8B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $830M | $960M | $1B | $1B | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $922M | $1.1B | $1.1B | $1.1B | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1B | $299M | $967M | $381M | -- | |
| Earnings of Discontinued Ops. | $5M | -$1M | -$19M | -$2M | -- | |
| Income Tax Expense | $247M | $76M | $231M | $103M | -- | |
| Net Income to Company | $801M | $223M | $718M | $277M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $802M | $222M | $717M | $276M | -- | |
| Basic EPS (Cont. Ops) | $16.10 | $4.47 | $14.40 | $5.59 | -- | |
| Diluted EPS (Cont. Ops) | $16.02 | $4.45 | $14.35 | $5.55 | -- | |
| Weighted Average Basic Share | $198.9M | $199.7M | $199.2M | $198.4M | -- | |
| Weighted Average Diluted Share | $199.8M | $200.2M | $199.9M | $201.6M | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.4B | $801M | $1.8B | $1.3B | -- | |
| Revenue (Reported) | $3.3B | $3.9B | $4.3B | $3.8B | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.4B | $801M | $1.8B | $1.3B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.8B | $3B | $3.9B | $3.6B | $3.7B | |
| Short Term Investments | $225M | $175M | $95M | $171M | $170M | |
| Accounts Receivable, Net | $114M | $151M | $164M | $144M | $145M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.1B | $3.4B | $4.2B | $3.9B | $4B | |
| Property Plant And Equipment | $332M | $312M | $283M | $265M | $229M | |
| Long-Term Investments | $225M | $289M | $227M | $253M | $266M | |
| Goodwill | $634M | $634M | $634M | $634M | $634M | |
| Other Intangibles | $77M | $53M | $165M | $128M | $112M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $22.5B | $21.7B | $25.4B | $23.1B | $22.9B | |
| Accounts Payable | $354M | $291M | $398M | $422M | $326M | |
| Accrued Expenses | $384M | $314M | $306M | $273M | $295M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.1B | $918M | $1B | $981M | $871M | |
| Long-Term Debt | $8.5B | $7.4B | $8B | $5.3B | $5.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $21B | $19.7B | $23.1B | $20.2B | $19.8B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $1.5B | $2.1B | $2.3B | $2.9B | $3.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.5B | $2.1B | $2.3B | $2.9B | $3.1B | |
| Total Liabilities and Equity | $22.5B | $21.7B | $25.4B | $23.1B | $22.9B | |
| Cash and Short Terms | $3B | $3.2B | $4B | $3.8B | $3.8B | |
| Total Debt | $8.5B | $7.4B | $8B | $5.3B | $5.6B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.8B | $3B | $3.9B | $3.6B | $3.7B | |
| Short Term Investments | $225M | $175M | $95M | $171M | $170M | |
| Accounts Receivable, Net | $114M | $151M | $164M | $144M | $145M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.1B | $3.4B | $4.2B | $3.9B | $4B | |
| Property Plant And Equipment | $332M | $312M | $283M | $265M | $229M | |
| Long-Term Investments | $225M | $289M | $227M | $253M | $266M | |
| Goodwill | $634M | $634M | $634M | $634M | $634M | |
| Other Intangibles | $77M | $53M | $165M | $128M | $112M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $22.5B | $21.7B | $25.4B | $23.1B | $22.9B | |
| Accounts Payable | $354M | $291M | $398M | $422M | $326M | |
| Accrued Expenses | $384M | $314M | $306M | $273M | $295M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.1B | $918M | $1B | $981M | $871M | |
| Long-Term Debt | $8.5B | $7.4B | $8B | $5.3B | $5.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $21B | $19.7B | $23.1B | $20.2B | $19.8B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.5B | $2.1B | $2.3B | $2.9B | $3.1B | |
| Total Liabilities and Equity | $22.5B | $21.7B | $25.4B | $23.1B | $22.9B | |
| Cash and Short Terms | $3B | $3.2B | $4B | $3.8B | $3.8B | |
| Total Debt | $8.5B | $7.4B | $8B | $5.3B | $5.6B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $214M | $801M | $223M | $718M | $277M | |
| Depreciation & Amoritzation | $184M | $123M | $113M | $116M | $90M | |
| Stock-Based Compensation | $21M | $29M | $33M | $44M | $54M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.9B | $1.5B | $1.8B | $2B | $1.9B | |
| Capital Expenditures | $54M | -- | -- | -- | -- | |
| Cash Acquisitions | -$267M | -$75M | -- | -- | -- | |
| Cash From Investing | $1.8B | -$1.7B | -$5.1B | $788M | -$1.2B | |
| Dividends Paid (Ex Special Dividend) | -$61M | -$42M | -$43M | -$42M | -$43M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.7B | $5B | $4.5B | $4B | $2.7B | |
| Long-Term Debt Repaid | -$5.4B | -$5.4B | -$3.9B | -$6.7B | -$2.6B | |
| Repurchase of Common Stock | -- | -- | -$12M | -$35M | -$55M | |
| Other Financing Activities | -$15M | -$144M | -$16M | -$104M | -$22M | |
| Cash From Financing | -$4.2B | $608M | $3.3B | -$3.1B | -$592M | |
| Beginning Cash (CF) | $4B | $3.5B | $3.9B | $3.9B | $3.6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$510M | $460M | $4M | -$311M | $98M | |
| Ending Cash (CF) | $3.5B | $3.9B | $3.9B | $3.6B | $3.7B | |
| Levered Free Cash Flow | $1.8B | $1.5B | $1.8B | $2B | $1.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $12.3M | $18M | -$134M | $43M | $7M | |
| Depreciation & Amoritzation | $63.7M | $26M | $33M | $24M | $22M | |
| Stock-Based Compensation | $4.8M | $4M | $9M | $12M | $13M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $394.4M | $335M | $497M | $617M | $479M | |
| Capital Expenditures | $16.1M | -$59M | -$58M | -$27M | -$29M | |
| Cash Acquisitions | -$293.7M | -- | -- | -- | -- | |
| Cash From Investing | -$1.6B | -$2.1B | -$3.6B | -$1.8B | -$1.4B | |
| Dividends Paid (Ex Special Dividend) | -$10.5M | -$11M | -$11M | -$10M | -$11M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2.1B | $2.2B | $2.5B | $1.7B | $1.1B | |
| Long-Term Debt Repaid | -$841.5M | -$1.4B | -$450M | -$608M | -$183M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$44M | |
| Other Financing Activities | $2B | -$129M | -$2M | -$12M | -$6M | |
| Cash From Financing | $897.3M | $1.8B | $3.4B | $1.4B | $1.1B | |
| Beginning Cash (CF) | $3.8B | $3.9B | $3.6B | $3.4B | $3.5B | |
| Foreign Exchange Rate Adjustment | $11.3M | $4M | -- | -- | -- | |
| Additions / Reductions | -$299.1M | $28M | $319M | $221M | $243M | |
| Ending Cash (CF) | $3.5B | $3.9B | $3.9B | $3.6B | $3.7B | |
| Levered Free Cash Flow | $378.3M | $394M | $555M | $644M | $508M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $214M | $801M | $223M | $718M | $277M | |
| Depreciation & Amoritzation | $184M | $123M | $113M | $116M | $90M | |
| Stock-Based Compensation | $21M | $29M | $33M | $44M | $54M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.9B | $1.5B | $1.8B | $2B | $1.9B | |
| Capital Expenditures | $54M | -- | -- | -- | -- | |
| Cash Acquisitions | -$267M | -- | -- | -- | -- | |
| Cash From Investing | $1.8B | -$1.7B | -$5.1B | $788M | -$1.2B | |
| Dividends Paid (Ex Special Dividend) | -$61M | -$42M | -$43M | -$42M | -$43M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.7B | $5B | $4.5B | $4B | $2.7B | |
| Long-Term Debt Repaid | -$5.4B | -$5.4B | -$3.9B | -$6.7B | -$2.6B | |
| Repurchase of Common Stock | -- | -- | -- | -$35M | -$55M | |
| Other Financing Activities | -$15M | -$144M | -$16M | -$104M | -$22M | |
| Cash From Financing | -$4.2B | $608M | $3.3B | -$3.1B | -$592M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$510M | $460M | $4M | -$311M | $98M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.8B | $1.5B | $1.8B | $2B | $1.9B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $801M | $223M | $718M | $277M | -- | |
| Depreciation & Amoritzation | $123M | $113M | $116M | $90M | -- | |
| Stock-Based Compensation | $29M | $33M | $44M | $54M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.5B | $1.8B | $2B | $1.9B | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.7B | -$5.1B | $788M | -$1.2B | -- | |
| Dividends Paid (Ex Special Dividend) | -$42M | -$43M | -$42M | -$43M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $5B | $4.5B | $4B | $2.7B | -- | |
| Long-Term Debt Repaid | -$5.4B | -$3.9B | -$6.7B | -$2.6B | -- | |
| Repurchase of Common Stock | -- | -$12M | -$35M | -$55M | -- | |
| Other Financing Activities | -$144M | -$16M | -$104M | -$22M | -- | |
| Cash From Financing | $608M | $3.3B | -$3.1B | -$592M | -- | |
| Beginning Cash (CF) | $14B | $14.9B | $14.3B | $15B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $460M | $4M | -$311M | $98M | -- | |
| Ending Cash (CF) | $14.4B | $14.9B | $14B | $15.1B | -- | |
| Levered Free Cash Flow | $1.5B | $1.8B | $2B | $1.9B | -- | |
Get BFH Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BFH
Sector
P/E ratio
9.29x
11.37x
PEG ratio
--
0.38x
P/B ratio
0.83x
1.07x
Price / LTM sales
0.68x
2.49x
Growth Metrics
BFH
Sector
Revenue growth
-9.05%
6.83%
Earnings growth
-84.44%
7.04%
Revenue (5-year growth)
2.77%
5.22%
Earnings forecast
$2.24
$0.58
Profitability
BFH
Sector
Profitability FY 2025
--
$157.3M
Return on invested capital
3.44%
5.5%
Return on assets
1.23%
0.99%
Return on equity
9.03%
9.5%
Earnings Date
Last Earnings Date
Jan
30
Next Earnings Date
Apr
25
Estimated Next Earnings Date
May
1
Balance Sheet
BFH
Sector
Total cash
$3.8B
$470.2M
Short term investments
$170M
$259.5M
Total assets
$22.9B
$4.5B
Long term debt
$5.6B
$340.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is LUV Stock a Buy, Sell or Hold?
Southwest Airlines (NYSE:LUV) is one of America’s major air transportation…
Should I Buy Alcoa Stock?
Alcoa (AA) finds itself in an interesting position in early…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
43
MNPR alert for Apr 3
Monopar Therapeutics [MNPR] is down 10.04% over the past day.
Buy
75
BKTI alert for Apr 3
BK Technologies [BKTI] is down 7.68% over the past day.
Sell
34
SWTX alert for Apr 3
SpringWorks Therapeutics [SWTX] is down 7.29% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
